CoChat

Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in Schizophrenia

Open access
Tregellas, Jason R., Tanabe, Jody, Rojas, Donald C., Shatti, Shireen, Olincy, Ann, Johnson, Lynn, Martin, Laura F., Soti, Ferenc, Kem, William R., Leonard, Sherry, Freedman, Robert · 2011 · Biological Psychiatry
Cited by 106

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background 3-(2,4-Dimethoxybenzylidene)-anabaseine (DMXB-A) is a partial agonist at α7 nicotinic acetylcholine receptors that has been evaluated clinically for treatment of schizophrenia. The current study examined the effects of DMXB-A on default network activity as a biomarker for drug effects on pathological brain function associated with schizophrenia. Methods Placebo and two doses of DMXB-A were administered in a random, double-blind crossover design during a one-month Phase-2 study of DMXB-A. Functional magnetic resonance imaging (fMRI) was performed on 16 non-smoking patients with schizophrenia while they performed a simple eye movement task. Independent component analysis was used to identify the default network component. Default network changes were evaluated in the context of a polymorphism in CHRNA7, the α7-nicotinic acetylcholine receptor subunit gene, which was previously found to be associated with schizophrenia. Results Compared to placebo, both 150 mg and 75 mg b.i.d. DMXB-A altered default network activity, including a reduction in posterior cingulate, inferior parietal cortex and medial frontal gyrus activity, and an increase in precuneus activity. The most robust difference, posterior cingulate activity reduction, was affected by CHRNA7 genotype. Conclusion The observed DMXB-A-related changes are consistent with improved default network function in schizophrenia. Pharmacogenetic analysis indicates mediation of the effect through the α7-nicotinic receptor. These results further implicate nicotinic cholinergic dysfunction in the disease and suggest that default network activity may be a useful indicator of biologic effects of novel therapeutic agents.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2010.07.004

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 106

Metadata

Authors
Tregellas, J. R., Tanabe, J., Rojas, D. C., Shatti, S., Olincy, A., Johnson, L., Martin, L. F., Soti, F., Kem, W. R., Leonard, S., & Freedman, R.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2011-01
Volume
69
Issue
1
Pages
7-11
ISSN
0006-3223 (ISSN-L)
OpenAlex
W1991156290
Cited by
106
References
8
FWCI
9.17
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in Schizophrenia. https://app.cochat.ai/papers/10.1016/j.biopsych.2010.07.004
The paper
Tregellas, J. R., Tanabe, J., Rojas, D. C., Shatti, S., Olincy, A., Johnson, L., Martin, L. F., Soti, F., Kem, W. R., Leonard, S., & Freedman, R. (2011). Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in Schizophrenia. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2010.07.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.